PremiumCompany AnnouncementsBiotron Limited Launches $2.7 Million Rights Issue Biotron Limited Updates Rights Issue Timetable Biotron Limited Updates Timetable for Securities Issue PremiumCompany AnnouncementsBiotron Limited Updates Timetable for Securities Issue Biotron Limited Commences Rights Trading on ASX Biotron Limited Addresses ASX Query on Market-Sensitive Announcement PremiumCompany AnnouncementsBiotron Limited Launches $2.7 Million Rights Issue to Fund Antiviral Program Expansion Biotron Limited Advances HIV-1 Treatment and Expands Viral Disease Programs Biotron Limited Announces Major Securities Issue to Boost Growth